Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 50MG/VIAL | 0 | NIPRIDE | SODIUM NITROPRUSSIDE |
FDA Submissions
TYPE 1; Type 1 - New Molecular Entity | ORIG | 1 | AP | 1974-05-10 | PRIORITY |
LABELING; Labeling | SUPPL | 6 | AP | 1977-12-27 | |
LABELING; Labeling | SUPPL | 9 | AP | 1979-01-23 | |
LABELING; Labeling | SUPPL | 10 | AP | 1981-02-13 | |
LABELING; Labeling | SUPPL | 12 | AP | 1985-05-15 | |
LABELING; Labeling | SUPPL | 18 | AP | 1984-07-30 | |
LABELING; Labeling | SUPPL | 21 | AP | 1987-05-27 | |
LABELING; Labeling | SUPPL | 23 | AP | 1990-10-18 | |
CDER Filings
ROCHE
cder:Array
(
[0] => Array
(
[ApplNo] => 17546
[companyName] => ROCHE
[docInserts] => ["",""]
[products] => [{"drugName":"NIPRIDE","activeIngredients":"SODIUM NITROPRUSSIDE","strength":"50MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"NIPRIDE","submission":"SODIUM NITROPRUSSIDE","actionType":"50MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)